Valuation check: SRTS's profit margin is -88.45%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for SRTS is -88.45% as of June 2026. That compares with -2.26% in the prior-year period — down 3818.1% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Sensus Healthcare's historical trend and sector peers before judging valuation or financial health.
Over the past year, SRTS's profit margin moved from -2.26% to -88.45% — a 3818.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sensus Healthcare's valuation or profitability profile.
Against Healthcare companies, SRTS currently prints -88.45% for profit margin, while the sector average sits near 13.89%. That is roughly 736.7% below the sector mean. Large gaps often invite a closer look at Sensus Healthcare's growth, margins, and balance sheet.
Profit Margin shows how effectively Sensus Healthcare converts resources into returns. At -88.45%, SRTS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2.26% in the prior-year period — down 3818.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SRTS's profit margin (-88.45%), review year-over-year change from -2.26%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.